在多个系统缩病变的自-溶酶体路径发病:最好的还没有到来
Panagiota Mavroeidi1, Maria Xilouri1
1Center of Clinical Research, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece.
International journal of molecular sciences
|October 29, 2025
概括
多系统性缩 (MSA) 涉及α-Synuclein积累和自-溶酶体通路 (ALP) 功能障碍. 本综述考察了MSA病理学,ALP损伤以及针对实验模型中自的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 包括帕金森病 (PD) 和多重系统缩 (MSA) 在内的α-synuclein病变,以α-synuclein蛋白质聚合物的积累为特征.
- 自-溶酶体通路 (ALP) 对于细胞蛋白质降解至关重要,其功能障碍与神经退行性疾病有关.
- 建立了溶酶体功能障碍 (例如,GBA1突变) 和PD病原体之间的遗传联系,在MSA中出现了新的证据.
研究的目的:
- 审查MSA的病理特征,重点关注α-Synuclein积累.
- 检查与MSA相关的自-溶酶体通路 (ALP) 内的损伤.
- 讨论在实验MSA模型中针对自的当前挑战和未来治疗策略.
主要方法:
- 对人类死后大脑研究,细胞模型和α-Synucleinopathies动物模型的文献评论.
- 分析了PD和MSA中组织病理学标志和蛋白质聚合的数据.
- 检查了关于自-溶解体途径在MSA病变发生过程中的作用的研究.
主要成果:
- 在神经元 (PD) 或寡干细胞 (MSA) 中的α-synuclein积累是一个关键的本病学特征.
- 证据表明,在α-Synucleinopathies中,自-溶酶体通路的成分发生了变化,影响了α-Synuclein降解.
- 与PD中的GBA1突变相关的溶酶体功能障碍显示出α-Synuclein沉积的相关增加,MSA的数据较少.
结论:
- 自-溶酶体通路与α-Synuclein积累一起,在MSA病原发生过程中具有关键作用.
- 了解MSA中的ALP障碍对于开发有针对性的治疗干预措施至关重要.
- 需要对实验MSA模型进行进一步的研究,以探索自细胞向策略.
关键词:
自自是自的过程.溶解体是溶解体的组成部分.多个系统缩 (MSA)神经退行症的神经退行症类质细胞 (Oligodendrocytes) 是一种有机细胞.治疗药物 治疗药物α-Synuclein 是一种蛋白质.更多相关视频
09:29Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
Published on: May 4, 2016
7.5K
06:58Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
Published on: October 18, 2024
1.2K
相关概念视频
Delivery Pathways to the Lysosome
8.7K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.7K
Autophagy
5.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.6K
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
The Proteasome
4.4K
4.4K
